Skip to content

Intravenous Granisetron Vs Dexmedetomidine on Postspinal in the Cesarean Section.

The Effect of Intravenous Granisetron Versus Intravenous Dexmedetomidine on Shivering Following Spinal Anesthesia in the Cesarean Section. a Randomized Controlled Comparative Trial .

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06762860
Enrollment
99
Registered
2025-01-08
Start date
2024-01-01
Completion date
2025-02-28
Last updated
2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postspinal Shivering

Keywords

shivering after spinal anesthesia in cesarean section

Brief summary

The Aim of this study is to investigate and compare the efficacy of intravenous Dexmedetomidine (0.3 ug/kg) versus intravenous Granisetron (3 mg) in the prevention of shivering in parturient undergoing cesarean section under spinal anesthesia.

Detailed description

Study groups: Randomization will be done according to computer guided table with sealed closed envelopes prepared by the supervisor, All study drugs will be prepared by the supervisor. Each group will be 25 patients.

Interventions

DRUGDexmedetomidine

label sticker

DRUGGranisetron

label sticker

OTHERPlacebo

label sticker

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Group C: Patients in this group will receive 10 ml normal saline (0.9%) over 10minutes immediately after clamping of the cord (control group). Group D: Patients in this group will receive (0.3 ug/kg) intravenous Dexmedetomidine added to normal saline to get 10 ml of colorless solution and injected over 10 minutes after clamping of the cord. Group G: Patients in this group will receive 3 mg intravenous Granisetron added to normal saline to get 10 ml of colorless solution and injected over 10 minutes immediately after clamping of the cord.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* patients scheduled for cesarean section under spinal anesthesia. * age : (20-45) years old. * American Society of Anesthesia (ASA) physical status I, II.

Exclusion criteria

* Patient refusal. * Contraindication to spinal anesthesia. * BMI \> 35 kg/m². * Impaired renal, hepatic and cardiac function. * Thyroid disease. * Body temperature \>38 °C or \< 36.5 °C.

Design outcomes

Primary

MeasureTime frameDescription
The incidence and severity of post spinal shivering.every 10 minutes intraoperatively and every 15 minutes postoperatively for 4 hours-The Shivering will be graded on a scale Tsai and Chu \[Tsai et al .,2001\] : Grade 0= No shivering. Grade 1=Piloerection or peripheral vasoconstriction but no visible shivering. Grade 2=Muscular activity in only one muscle group. Grade 3=Muscular activity in more than one muscle group but not generalized. Grade 4=Shivering involving the whole body.

Secondary

MeasureTime frameDescription
change in the basal axillary temperature.preoperatively, immediately after spinal block and at 5 ,15 ,30 ,45 minutes and at the end of surgery, then every 15 minutes for 4 hour postoperativelyChanges in basal axillary temperature (Celsius (°C) scale) of the patient after administration of tested drugs.
change in the basal mean arterial blood pressurepreoperatively, immediately after spinal block and at 5 ,15 ,30 ,45 minutes and at the end of surgery, then every 15 minutes for 4 hour postoperatively.Changes in the basal non-invasive mean arterial blood pressure( millimetres mercury (mmHg)) of the patient after administration of tested drugs.
Change in the basal heart ratepreoperatively, immediately after spinal block and at 5 ,15 ,30 ,45 minutes and at the end of surgery, then every 15 minutes for 4 hour postoperatively.Change in the heart rate of the patient after administration of tested drugs (beat per minute)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026